Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.
Award ID | Description | Recipient | Total Value | Awarding Agency | Funding Agency | Set Aside | NAICS | PSC | Award Date | Start Date | End Date | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LABORATORY SUPPORT SERVICES - QUANTIFICATION OF PHENSERINE IN HUMAN PLASMA SAMPLES | UNIVERSITY OF EXETER | $24,750 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541380Testing Laboratories and Services | Q301MEDICAL- LABORATORY TESTING | Sep 6, 2024 | Sep 20, 2024 | Sep 19, 2025 | ||
| CLINICAL EVALUATION OF PHENSERINE TARTRATE EXTENDED CONTROLLED RELEASE TABLET (ECRT) FORMULATION IN EARLY MILD ALZHEIMER'S DISEASE AND MILD TO MODERATE TRAUMATIC BRAIN INJURY. | UNIVERSITY OF EXETER | $962,486 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541990All Other Professional, Scientific, and Technical Services | B504SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL | Jan 31, 2024 | Feb 1, 2024 | Jan 31, 2026 | ||
| UNDERSTANDING TWO NOVEL FACTORS RELATED TO MOTOR IMPAIRMENT IN THE DEVELOPMENT OF DEMENTIA - UK BIOBANK PROJECT | UNIVERSITY OF EXETER | $546,052 | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH | — | 541990All Other Professional, Scientific, and Technical Services | B504SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL | Nov 24, 2021 | Nov 29, 2021 | Nov 28, 2024 | ||
| WHY AN EFFECTIVE MELIOIDOSIS/GLANDERS VACCINE MAY NOT BE POSSIBLE R&D EFFORT | UNIVERSITY OF EXETER | $1,703,597 | DEFENSE THREAT REDUCTION AGENCY (DTRA) | DEFENSE THREAT REDUCTION AGENCY (DTRA) | — | 541711 | AD91 | Apr 26, 2012 | Apr 23, 2012 | Jul 31, 2015 |